Rawshani A, Sattar N, Franzén S, Rawshani A, Hattersley AT, Svensson A-M, Eliasson B, Gudbjörnsdottir S. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392(10146):477–86. https://doi.org/10.1016/S0140-6736(18)31506-X.
Article
PubMed
PubMed Central
Google Scholar
Lind M, Svensson A-M, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972–82. https://doi.org/10.1056/NEJMoa1408214.
Article
CAS
PubMed
Google Scholar
Amor AJ, Vinagre I, Valverde M, Pané A, Urquizu X, Meler E, López E, Quirós C, Giménez M, Codina L, Conget I, Barahona MJ, Perea V. Preeclampsia Is associated with increased preclinical carotid atherosclerosis in women with type 1 diabetes. J Clin Endocrinol Metab. 2020. https://doi.org/10.1210/clinem/dgz031.
Article
PubMed
Google Scholar
Carbonell M, Castelblanco E, Valldeperas X, Betriu À, Traveset A, Granado-Casas M, Hernández M, Vázquez F, Martín M, Rubinat E, Lecube A, Franch-Nadal J, Fernández E, Puig-Domingo M, Avogaro A, Alonso N, Mauricio D. Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes. Cardiovasc Diabetol. 2018;17(1):66. https://doi.org/10.1186/s12933-018-0706-z.
Article
CAS
PubMed
PubMed Central
Google Scholar
de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, Zinman B, Eckel RH. Type 1 diabetes mellitus and cardiovascular disease: a Scientific Statement From the American Heart Association and American Diabetes Association. Diabetes Care. 2014;37(10):2843–63. https://doi.org/10.2337/dc14-1720.
Article
PubMed
PubMed Central
Google Scholar
Rawshani A, Rawshani A, Sattar N, Franzén S, McGuire DK, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, Rosengren A, Gudbjörnsdottir S. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2019;139(16):1900–12. https://doi.org/10.1161/CIRCULATIONAHA.118.037454.
Article
PubMed
Google Scholar
Vaisar T, Kanter JE, Wimberger J, Irwin AD, Gauthier J, Wolfson E, Bahnam V, Wu I-H, Shah H, Keenan HA, Greenbaum CJ, King GL, Heinecke JW, Bornfeldt KE. High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes. Diabetes Care. 2019. https://doi.org/10.2337/dc19-0772.
Article
PubMed
PubMed Central
Google Scholar
Bebu I, Braffett BH, Orchard TJ, Lorenzi GM, Lachin JM, and the DCCT/EDIC Research Group. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT/EDIC Study. Diabetes Care. 2019. https://doi.org/10.2337/dc18-1613.
Article
PubMed
PubMed Central
Google Scholar
Diabetes Control and Complications Trial Research Group. Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group. Diabetes Care. 1992;15(7):886–94. https://doi.org/10.2337/diacare.15.7.886.
Article
Google Scholar
Maahs DM, Hokanson JE, Wang H, Kinney GL, Snell-Bergeon JK, East A, Bergman BC, Schauer IE, Rewers M, Eckel RH. Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance. Diabetes. 2010;59(7):1771–9. https://doi.org/10.2337/db09-1626.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hughes TA, Calderon RM, Diaz S, Mendez AJ, Goldberg RB. Lipoprotein composition in patients with type 1 diabetes mellitus: impact of lipases and adipokines. J Diabetes Complications. 2016;30(4):657–68. https://doi.org/10.1016/j.jdiacomp.2016.01.018.
Article
PubMed
Google Scholar
Brugnara L, Mallol R, Ribalta J, Vinaixa M, Murillo S, Casserras T, Guardiola M, Vallvé JC, Kalko SG, Correig X, Novials A. Improving assessment of lipoprotein profile in type 1 diabetes by 1H NMR spectroscopy. Zhang Y, ed. PLoS ONE. 2015;10(8):e0136348. https://doi.org/10.1371/journal.pone.0136348.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bervoets L, Massa G, Guedens W, Louis E, Noben J-P, Adriaensens P. Metabolic profiling of type 1 diabetes mellitus in children and adolescents: a case–control study. Diabetol Metab Syndr. 2017;9(1):48. https://doi.org/10.1186/s13098-017-0246-9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Llauradó G, Amigó N, Cano A, Ballesta S, Albert L, Mazarico I, Fernández-Veledo S, Pedro-Botet J, Vendrell J, González-Clemente J-M. Specific nuclear magnetic resonance lipoprotein subclass profiles and central arterial stiffness in type 1 diabetes mellitus: a case control study. J Clin Med. 2019;8(11):1875. https://doi.org/10.3390/jcm8111875.
Article
CAS
PubMed Central
Google Scholar
Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN. Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study. Cardiovasc Diabetol. 2018;17(1):158. https://doi.org/10.1186/s12933-018-0802-0.
Article
CAS
PubMed
PubMed Central
Google Scholar
Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes. 2002;51(6):1949–56. https://doi.org/10.2337/diabetes.51.6.1949.
Article
CAS
PubMed
Google Scholar
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88. https://doi.org/10.1093/eurheartj/ehz455.
Article
PubMed
Google Scholar
Vilanova MB, Falguera M, Marsal JR, Rubinat E, Alcubierre N, Castelblanco E, Granado-Casas M, Miró N, Molló À, Mata-Cases M, Franch-Nadal J, Mauricio D. Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study. BMJ Open. 2017;7(6):e015158. https://doi.org/10.1136/bmjopen-2016-015158.
Article
PubMed
PubMed Central
Google Scholar
Viñals C, Conget I, Pané A, Boswell L, Perea V, Blanco A, Ruiz S, Giménez M, Vinagre I, Esmatjes E, Ortega E, Amor A. Steno type 1 risk engine and preclinical atherosclerosis in Mediterranean individuals with type 1 diabetes. Diabetes Metab Res Rev. 2020. https://doi.org/10.1002/dmrr.3320.
Article
PubMed
Google Scholar
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. J Am Coll Cardiol. 2018. https://doi.org/10.1016/j.jacc.2018.11.003.
Article
PubMed
Google Scholar
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation. Int Circ. 2009;120(16):1640–5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644.
Article
CAS
Google Scholar
Nordestgaard BG, Langlois MR, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Atherosclerosis. 2020;294:46–61. https://doi.org/10.1016/j.atherosclerosis.2019.12.005.
Article
CAS
PubMed
Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
PubMed
PubMed Central
Google Scholar
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33. https://doi.org/10.1186/1471-230X-6-33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dabelea D, D’Agostino RB, Mason CC, West N, Hamman RF, Mayer-Davis EJ, Maahs D, Klingensmith G, Knowler WC, Nadeau K. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for diabetes in youth study. Diabetologia. 2011;54(1):78–86. https://doi.org/10.1007/s00125-010-1911-9.
Article
CAS
PubMed
Google Scholar
Mallol R, Amigó N, Rodríguez MA, Heras M, Vinaixa M, Plana N, Rock E, Ribalta J, Yanes O, Masana L, Correig X. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res. 2015;56(3):737–46. https://doi.org/10.1194/jlr.D050120.
Article
CAS
PubMed
PubMed Central
Google Scholar
Amor AJ, Catalan M, Pérez A, Herreras Z, Pinyol M, Sala-Vila A, Cofán M, Gilabert R, Ros E, Ortega E. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis. Atherosclerosis. 2016;247:161–9. https://doi.org/10.1016/j.atherosclerosis.2016.02.014.
Article
CAS
PubMed
Google Scholar
Amor AJ, Pinyol M, Solà E, Catalan M, Cofán M, Herreras Z, Amigó N, Gilabert R, Sala-Vila A, Ros E, Ortega E. Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: a focus on atherogenic dyslipidemia. J Clin Lipidol. 2017;11(2):551–561.e7. https://doi.org/10.1016/j.jacl.2017.02.001.
Article
PubMed
Google Scholar
Gourgari E, Ma J, Playford MP, Mehta NN, Goldman R, Remaley AT, Gordon SM. Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study. Cardiovasc Diabetol. 2019. https://doi.org/10.1186/s12933-019-0846-9.
Article
PubMed
PubMed Central
Google Scholar
Damasceno NRT, Sala-Vila A, Cofán M, Pérez-Heras AM, Fitó M, Ruiz-Gutiérrez V, Martínez-González MÁ, Corella D, Arós F, Estruch R, Ros E. Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk. Atherosclerosis. 2013;230(2):347–53. https://doi.org/10.1016/j.atherosclerosis.2013.08.014.
Article
CAS
PubMed
Google Scholar
Granado-Casas M, Alcubierre N, Martín M, Real J, Ramírez-Morros AM, Cuadrado M, Alonso N, Falguera M, Hernández M, Aguilera E, Lecube A, Castelblanco E, Puig-Domingo M, Mauricio D. Improved adherence to Mediterranean Diet in adults with type 1 diabetes mellitus. Eur J Nutr. 2019;58(6):2271–9. https://doi.org/10.1007/s00394-018-1777-z.
Article
PubMed
Google Scholar
Huxley RR, Peters SAE, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(3):198–206. https://doi.org/10.1016/S2213-8587(14)70248-7.
Article
PubMed
Google Scholar
Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH. Factors associated with plasma lipids and lipoproteins in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med. 2001;18(10):786–96. https://doi.org/10.1046/j.0742-3071.2001.00571.x.
Article
CAS
PubMed
Google Scholar
Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018;18(12):127. https://doi.org/10.1007/s11892-018-1101-6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Giuffrida FMA, Guedes AD, Rocco ER, Mory DB, Dualib P, Matos OS, Chaves-Fonseca RM, Cobas RA, Negrato CA, Gomes MB, Dib SA, Matheus A, Tannus L, Zajdenverg L, Rodacki M, de Araujo NBC, de Menezes Cordeiro M, Luescher JL, Berardo RS, et al. Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey. Cardiovasc Diabetol. 2012. https://doi.org/10.1186/1475-2840-11-156.
Article
PubMed
PubMed Central
Google Scholar
Mäkinen V-P, Soininen P, Kangas AJ, Forsblom C, Tolonen N, Thorn LM, Viikari J, Raitakari OT, Savolainen M, Groop P-H, Ala-Korpela M, Finnish Diabetic Nephropathy Study Group. Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study. J Intern Med. 2013;273(4):383–95. https://doi.org/10.1111/joim.12026.
Article
CAS
PubMed
Google Scholar
Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Garvey WT, Lyons TJ. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis. 2016;244:93–100. https://doi.org/10.1016/j.atherosclerosis.2015.10.106.
Article
CAS
PubMed
Google Scholar
Nyström T, Holzmann MJ, Eliasson B, Svensson A-M, Sartipy U. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metab. 2018;20(3):556–63. https://doi.org/10.1111/dom.13110.
Article
CAS
PubMed
Google Scholar
Šimonienė D, Platūkiene A, Prakapienė E, Radzevičienė L, Veličkiene D. Insulin resistance in type 1 diabetes mellitus and its association with patient’s micro- and macrovascular complications, sex hormones, and other clinical data. Diabetes Ther. 2019. https://doi.org/10.1007/s13300-019-00729-5.
Article
PubMed
PubMed Central
Google Scholar
Pané A, Conget I, Boswell L, Ruiz S, Viñals C, Perea V, Giménez M, Cofán M, Blanco J, Vinagre I, Esmatjes E, Ortega E, Amor AJ. Insulin resistance is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. Diabetes Metab Res Rev. 2020. https://doi.org/10.1002/dmrr.3323.
Article
PubMed
Google Scholar
Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care. 2003;26(3):810–8. https://doi.org/10.2337/diacare.26.3.810.
Article
CAS
PubMed
Google Scholar
Abed E, Labarbera B, Dvorak J, Zhang Y, Beck J, Talsania M. Prevalence of dyslipidemia and factors affecting dyslipidemia in young adults with type 1 diabetes: evaluation of statin prescribing. J Pediatr Endocrinol Metab. 2019;32(4):327–34. https://doi.org/10.1515/jpem-2018-0383.
Article
CAS
PubMed
Google Scholar
Bojanin D, Vekic J, Milenkovic T, Vukovic R, Zeljkovic A, Stefanovic A, Janac J, Ivanisevic J, Mitrovic K, Miljkovic M, Spasojevic-Kalimanovska V. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: effects of glycemic control. Atherosclerosis. 2019;280:14–20. https://doi.org/10.1016/j.atherosclerosis.2018.11.020.
Article
CAS
PubMed
Google Scholar
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen M-R, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–72. https://doi.org/10.1093/eurheartj/ehx144.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjörnsdottir S. Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2017;135(16):1522–31. https://doi.org/10.1161/CIRCULATIONAHA.116.025961.
Article
PubMed
PubMed Central
Google Scholar
Svanteson M, Holte KB, Haig Y, Kløw NE, Berg TJ. Coronary plaque characteristics and epicardial fat tissue in long term survivors of type 1 diabetes identified by coronary computed tomography angiography. Cardiovasc Diabetol. 2019. https://doi.org/10.1186/s12933-019-0861-x.
Article
PubMed
PubMed Central
Google Scholar
Bebu I, Braffett BH, Pop-Busui R, Orchard TJ, Nathan DM, Lachin JM, DCCT/EDIC Research Group. The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study. Diabetologia. 2017;60(10):2084–91. https://doi.org/10.1007/s00125-017-4374-4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pichler G, Amigo N, Tellez-Plaza M, Pardo-Cea MA, Dominguez-Lucas A, Marrachelli VG, Monleon D, Martin-Escudero JC, Ascaso JF, Chaves FJ, Carmena R, Redon J. LDL particle size and composition and incident cardiovascular disease in a South-European population: the Hortega-Liposcale Follow-up Study. Int J Cardiol. 2018;264:172–8. https://doi.org/10.1016/j.ijcard.2018.03.128.
Article
CAS
PubMed
Google Scholar
Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011;5(2):105–13. https://doi.org/10.1016/j.jacl.2011.02.001.
Article
PubMed
PubMed Central
Google Scholar
Mora S, Buring JE, Ridker PM. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation. 2014;129(5):553–61. https://doi.org/10.1161/CIRCULATIONAHA.113.005873.
Article
CAS
PubMed
Google Scholar
Hagensen MK, Mortensen MB, Kjolby M, Stillits NL, Steffensen LB, Bentzon JF. Type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta. Atherosclerosis. 2017;263:7–14. https://doi.org/10.1016/j.atherosclerosis.2017.05.019.
Article
CAS
PubMed
Google Scholar
Mallol R, Rodriguez MA, Brezmes J, Masana L, Correig X. Human serum/plasma lipoprotein analysis by NMR: application to the study of diabetic dyslipidemia. Prog Nucl Magn Reson Spectrosc. 2013;70:1–24. https://doi.org/10.1016/j.pnmrs.2012.09.001.
Article
CAS
PubMed
Google Scholar
Vergès B. Dyslipidemia in type 1 diabetes: a masked danger. Trends Endocrinol Metab. 2020;31(6):422–34. https://doi.org/10.1016/j.tem.2020.01.015.
Article
CAS
PubMed
Google Scholar
Hasslacher C, Lorenzo Bermejo J. Treatment with insulin analogs and prevalence of cardiovascular complications in patients with type 1 diabetes. Ther Adv Endocrinol Metab. 2017;8(11):149–57. https://doi.org/10.1177/2042018817732732.
Article
CAS
PubMed
PubMed Central
Google Scholar